These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37782954)

  • 1. INTERACTIONS OF METFORMIN AND OTHER MEDICATIONS IN REDUCING THE ODDS OF AGE-RELATED MACULAR DEGENERATION IN A COHORT OF PATIENTS WITH DIABETES.
    Shaw L; Khanna S; Hyman MJ; Ham S; Blitzer A; Parvar SP; Soo J; Flores A; Hariprasad S; Skondra D
    Retina; 2024 Feb; 44(2):197-204. PubMed ID: 37782954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes.
    Aggarwal S; Moir J; Hyman MJ; Kaufmann GT; Flores A; Hariprasad SM; Skondra D
    JAMA Ophthalmol; 2024 Jan; 142(1):53-57. PubMed ID: 38019527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Metformin and Other Diabetes Medication Use and the Development of New-Onset Dry Age-Related Macular Degeneration: A Case-Control Study.
    Kaufmann GT; Hyman MJ; Gonnah R; Hariprasad S; Skondra D
    Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):22. PubMed ID: 37589984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Metformin Use With Age-Related Macular Degeneration: A Case-Control Study.
    Blitzer AL; Ham SA; Colby KA; Skondra D
    JAMA Ophthalmol; 2021 Mar; 139(3):302-309. PubMed ID: 33475696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration.
    Brown EE; Ball JD; Chen Z; Khurshid GS; Prosperi M; Ash JD
    Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1470-1477. PubMed ID: 30973575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association Between Metformin Use and New-Onset ICD Coding of Geographic Atrophy.
    Moir J; Hyman MJ; Gonnah R; Flores A; Hariprasad SM; Skondra D
    Invest Ophthalmol Vis Sci; 2024 Mar; 65(3):23. PubMed ID: 38497512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Oral Metformin Use and the Development of Age-Related Macular Degeneration in Diabetic Patients: A Systematic Review and Meta-Analysis.
    Liang KH; Chen CH; Tsai HR; Chang CY; Chen TL; Hsu WC
    Invest Ophthalmol Vis Sci; 2022 Dec; 63(13):10. PubMed ID: 36484633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study.
    Vergroesen JE; Thee EF; Ahmadizar F; van Duijn CM; Stricker BH; Kavousi M; Klaver CCW; Ramdas WD
    JAMA Ophthalmol; 2022 Jul; 140(7):674-681. PubMed ID: 35587864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Statins, Metformin, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers on Age-Related Macular Degeneration.
    Lee H; Jeon HL; Park SJ; Shin JY
    Yonsei Med J; 2019 Jul; 60(7):679-686. PubMed ID: 31250582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study.
    Roumie CL; Min JY; D'Agostino McGowan L; Presley C; Grijalva CG; Hackstadt AJ; Hung AM; Greevy RA; Elasy T; Griffin MR
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28424149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between metformin use and the risk of age-related macular degeneration in patients with type 2 diabetes: a retrospective study.
    Jiang J; Chen Y; Zhang H; Yuan W; Zhao T; Wang N; Fan G; Zheng D; Wang Z
    BMJ Open; 2022 Apr; 12(4):e054420. PubMed ID: 35473747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASSOCIATION OF METFORMIN USE WITH RISK OF NEWLY ONSET NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENT.
    Khanna S; Shaw L; Hyman MJ; Zhang J; Hariprasad S; Soo J; Flores A; Skondra D
    Retina; 2024 Feb; 44(2):205-213. PubMed ID: 38259182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and risk of age-related macular degeneration in individuals with type 2 diabetes: a retrospective cohort study.
    Gokhale KM; Adderley NJ; Subramanian A; Lee WH; Han D; Coker J; Braithwaite T; Denniston AK; Keane PA; Nirantharakumar K
    Br J Ophthalmol; 2023 Jul; 107(7):980-986. PubMed ID: 35115301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Diabetes Treatment and Monitoring among Medicare Beneficiaries.
    Landon BE; Zaslavsky AM; Souza J; Ayanian JZ
    J Gen Intern Med; 2018 Apr; 33(4):471-480. PubMed ID: 29427177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey.
    Le P; Chaitoff A; Misra-Hebert AD; Ye W; Herman WH; Rothberg MB
    Diabetes Care; 2020 Jun; 43(6):1227-1233. PubMed ID: 32234720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
    Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB
    Am J Ther; 2006; 13(5):400-3. PubMed ID: 16988534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations Between Autoimmune Disease and the Development of Age-Related Macular Degeneration.
    Moir J; Hyman MJ; Wang J; Shah A; Maatouk C; Flores A; Skondra D
    Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):45. PubMed ID: 38153747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
    Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.
    Roumie CL; Hung AM; Greevy RA; Grijalva CG; Liu X; Murff HJ; Elasy TA; Griffin MR
    Ann Intern Med; 2012 Nov; 157(9):601-10. PubMed ID: 23128859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
    Simons WR; Hagan MA
    Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.